Cargando…
Impact of COVID-19 pandemic on pharmacologic treatment of patients newly diagnosed with osteoporosis
PURPOSE: This study determined whether initiation of pharmacologic treatment was delayed for newly diagnosed osteoporosis patients during the COVID-19 pandemic. METHODS: 1,189 patients ≥50 years with newly diagnosed osteoporosis using dual-energy x-ray absorptiometry (DXA) screening at a single acad...
Autores principales: | White, Micaela, Hisatomi, Lauren, Villegas, Alex, Pina, Dagoberto, Garfinkel, Alec, Agrawal, Garima, Punatar, Nisha, Wise, Barton L., Teng, Polly, Le, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499214/ https://www.ncbi.nlm.nih.gov/pubmed/37703271 http://dx.doi.org/10.1371/journal.pone.0291472 |
Ejemplares similares
-
Portal Vein Thrombosis in the Setting of Newly Diagnosed Cushing’s Syndrome
por: McDow, Alexandria D., et al.
Publicado: (2017) -
Association of gastrointestinal events and osteoporosis treatment initiation in newly diagnosed osteoporotic Israeli women
por: Yu, J., et al.
Publicado: (2015) -
Clinical Management of Women with Newly Diagnosed Osteoporosis: Data from Everyday Practice in Bulgaria
por: Boyanov, Mihail A., et al.
Publicado: (2021) -
Pharmacological therapy of osteoporosis
por: Montalcini, T, et al.
Publicado: (2010) -
DPP4 Activities Are Associated with Osteopenia/Osteoporosis and Fracture Risk in Newly Diagnosed Type 2 Diabetes
por: Qiu, Min, et al.
Publicado: (2020)